4//SEC Filing
PTC THERAPEUTICS, INC. 4
Accession 0001179110-16-030616
$PTCTCIK 0001070081operating
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 6:12 AM ET
Size
13.9 KB
Accession
0001179110-16-030616
Insider Transaction Report
Form 4
Rothera Mark
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2016-10-10$10.85/sh+1,950$21,158→ 9,275 total - Exercise/Conversion
Stock Option (Right To Buy)
2016-10-10−1,950→ 80,384 totalExercise: $10.85Exp: 2023-05-15→ Common Stock (1,950 underlying)
Holdings
- 9,216(indirect: By Trust)
Common Stock
- 65,000
Stock Option (Right To Buy)
Exercise: $27.05Exp: 2024-01-27→ Common Stock (65,000 underlying) - 8,125
Stock Option (Right To Buy)
Exercise: $10.85Exp: 2023-05-15→ Common Stock (8,125 underlying) - 69,550
Stock Option (Right To Buy)
Exercise: $51.00Exp: 2025-01-01→ Common Stock (69,550 underlying) - 70,000
Stock Option (Right To Buy)
Exercise: $30.86Exp: 2026-01-03→ Common Stock (70,000 underlying)
Footnotes (6)
- [F1]This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- [F2]This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- [F3]This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- [F4]This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- [F5]This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- [F6]Shares held by trust of which reporting person's spouse is a beneficiary.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070081
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 6:12 AM ET
- Size
- 13.9 KB